Bone-metastatic prostate carcinoma favors mesenchymal stem cell differentiation toward osteoblasts and reduces their osteoclastogenic potential

Journal of Cellular Biochemistry

Volumn 112, Issue 11, 2011, Pages 3234-3245

  Fritz, V ^a,b,c   Brondello, J M ^a,b   Gordeladze, J O ^a,d   Reseland, J E ^d   Bony, C ^a,b   Yssel, H ^a,b   Noal D ^a,b   Jorgensen, C ^a,b,e  

^a HÔPITAL SAINT ELOI   (France)

^b UNIV MONTPELLIER   (France)

^c INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^d UNIVERSITY OF OSLO   (Norway)

^e LAPEYRONIE HOSPITAL   (France)

Author keywords

FGF 9; mesenchymal stem cells; osteoclastogenesis; osteogenesis; prostate carcinoma

Indexed keywords

FIBRONECTIN; OSTEOPROTEGERIN; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; BONE METASTATIC PROSTATE CARCINOMA CELL; CANCER CELL; CELL ACTIVITY; CELL DIFFERENTIATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MESENCHYMAL STEM CELL; OSSIFICATION; OSTEOBLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSCRIPTOMICS;

BONE NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; HUMANS; MALE; MESENCHYMAL STEM CELLS; OSTEOCLASTS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80055023959     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23258     Document Type: Article

References (57)

1. Adams JC, Watt FM,. 1993. Regulation of development and differentiation by the extracellular matrix. Development 117: 1183-1198. (Pubitemid 23154486)
2. Breen EC, Ignotz RA, McCabe L, Stein JL, Stein GS, Lian JB,. 1994. TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype. J Cell Physiol 160: 323-335.
3. Chanda D, Isayeva T, Kumar S, Hensel JA, Sawant A, Ramaswamy G, Siegal GP, Beatty MS, Ponnazhagan S,. 2009. Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis. Clin Cancer Res 15: 7175-7185.
4. Cross NA, Papageorgiou M, Eaton CL,. 2007. Bone marrow stromal cells promote growth and survival of prostate cancer cells. Biochem Soc Trans 35: 698-700. (Pubitemid 47310346)
5. Damsky C, Tremble P, Werb Z,. 1992. Signal transduction via the fibronectin receptor: Do integrins regulate matrix remodeling ? Matrix (Suppl 1): 184-191.
6. Dedhar S, Mitchell MD, Pierschbacher MD,. 1989. The osteoblast-like differentiated phenotype of a variant of MG-63 osteosarcoma cell line correlated with altered adhesive properties. Connect Tissue Res 20: 49-61.
7. Djouad F, Delorme B, Maurice M, Bony C, Apparailly F, Louis-Plence P, Canovas F, Charbord P, Noel D, Jorgensen C,. 2007. Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes. Arthritis Res Ther 9: R33.
8. Docheva D, Popov C, Mutschler W, Schieker M,. 2007. Human mesenchymal stem cells in contact with their environment: Surface characteristics and the integrin system. J Cell Mol Med 11: 21-38. (Pubitemid 46439623)
9. Eielson C, Kaplan D, Mitnick MA, Paliwal I, Insogna K,. 1994. Estrogen modulates parathyroid hormone-induced fibronectin production in human and rat osteoblast-like cells. Endocrinology 135: 1639-1644. (Pubitemid 24307544)
10. El-Amin SF, Attawia M, Lu HH, Shah AK, Chang R, Hickok NJ, Tuan RS, Laurencin CT,. 2002. Integrin expression by human osteoblasts cultured on degradable polymeric materials applicable for tissue engineered bone. J Orthop Res 20: 20-28. (Pubitemid 34071417)
11. El-Amin SF, Lu HH, Khan Y, Burems J, Mitchell J, Tuan RS, Laurencin CT,. 2003. Extracellular matrix production by human osteoblasts cultured on biodegradable polymers applicable for tissue engineering. Biomaterials 24: 1213-1221. (Pubitemid 36069129)
12. Fakhry A, Ratisoontorn C, Vedhachalam C, Salhab I, Koyama E, Leboy P, Pacifici M, Kirschner RE, Nah HD,. 2005. Effects of FGF-2/-9 in calvarial bone cell cultures: Differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 36: 254-266. (Pubitemid 40283582)
13. Franceschi RT, Xiao G, Jiang D, Gopalakrishnan R, Yang S, Reith E,. 2003. Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation. Connect Tissue Res 44 (Suppl 1): 109-116. (Pubitemid 36395431)
14. Fritz V, Louis-Plence P, Apparailly F, Noel D, Voide R, Pillon A, Nicolas JC, Muller R, Jorgensen C,. 2007. Micro-CT combined with bioluminescence imaging: A dynamic approach to detect early tumor-bone interaction in a tumor osteolysis murine model. Bone 40: 1032-1040. (Pubitemid 46386549)
15. Fritz V, Noel D, Bouquet C, Opolon P, Voide R, Apparailly F, Louis-Plence P, Bouffi C, Drissi H, Xie C, Perricaudet M, Muller R, Schwarz E, Jorgensen C,. 2008. Antitumoral activity and osteogenic potential of mesenchymal stem cells expressing the urokinase-type plasminogen antagonist amino-terminal fragment in a murine model of osteolytic tumor. Stem Cells 26: 2981-2990.
16. Holen I, Croucher PI, Hamdy FC, Eaton CL,. 2002. Osteopotegerin (OPG) is as survival factor for human prostate cancer cells. Cancer Res 62: 1619-1623. (Pubitemid 34408480)
17. Garofalo S, Kliger-Spatz M, Cooke JL, Wolstin O, Lunstrum GP, Moshkovitz SM, Horton WA, Yayon A,. 1999. Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice. J Bone Miner Res 14: 1909-1915. (Pubitemid 29521786)
18. Giri D, Ropiquet F, Ittmann M,. 1999. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin Cancer Res 5: 1063-1071. (Pubitemid 29233220)
19. Goltzman D, Bolivar I, Rabbani SA,. 1992. Studies on the pathogenesis of osteoblastic metastases by prostate cancer. Adv Exp Med Biol 324: 165-171. (Pubitemid 23007156)
20. Gronowicz GA, DeRome ME, McCarthy MB,. 1991. Glucocorticoids inhibit fibronectin synthesis and messenger ribonucleic acid levels in cultured fetal rat parietal bones. Endocrinology 128: 1107-1114.
21. Gronowicz GA, McCarthy MB,. 1995. Glucocorticoids inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease beta 1-integrin levels. Endocrinology 136: 598-608.
22. Hamidouche Z, Fromigue O, Ringe J, Haupl T, Vaudin P, Pages JC, Srouji S, Livne E, Marie PJ,. 2009. Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc Natl Acad Sci U S A 106: 18587-18591.
23. Hecht D, Zimmerman N, Bedford M, Avivi A, Yayon A,. 1995. Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4. Growth Factors 12: 223-233.
24. Hughes DE, Salter DM, Dedhar S, Simpson R,. 1993. Integrin expression in human bone. J Bone Miner Res 8: 527-533. (Pubitemid 23127912)
25. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z, Damsky CH,. 1995. Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 129: 867-879.
26. Hultenby K, Reinholt FP, Heinegard D,. 1993. Distribution of integrin subunits on rat metaphyseal osteoclasts and osteoblasts. Eur J Cell Biol 62: 86-93. (Pubitemid 23324682)
27. Ignelzi MA Jr, Wang W, Young AT,. 2003. Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures. J Bone Miner Res 18: 751-759. (Pubitemid 36899325)
28. Jackson RA, Nurcombe V, Cool SM,. 2006. Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. Gene 379: 79-91. (Pubitemid 44262446)
29. Jin C, Wang F, Wu X, Yu C, Luo Y, McKeehan WL,. 2004. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors. Cancer Res 64: 4555-4562. (Pubitemid 38856928)
30. Jorgensen C, Gordeladze J, Noel D,. 2004. Tissue engineering through autologous mesenchymal stem cells. Curr Opin Biotechnol 15: 406-410. (Pubitemid 39304035)
31. Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, Taichman RS,. 2001. Prostate carcinoma skeletal metastases: Cross-talk between tumor and bone. Canc Metastasis Rev 20: 333-349. (Pubitemid 34595275)
32. Koch H, Jadlowiec JA, Campbell PG,. 2005. Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev 14: 621-631. (Pubitemid 43201896)
33. Koeneman KS, Yeung F, Chung LW,. 1999. Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate 39: 246-261. (Pubitemid 29244499)
34. Kwabi-Addo B, Ozen M, Ittmann M,. 2004. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Canc 11: 709-724. (Pubitemid 40065546)
35. Lai CF, Cheng SL,. 2005. Alphavbeta integrins play an essential role in BMP-2 induction of osteoblast differentiation. J Bone Miner Res 20: 330-340.
36. Lee Y, Schwarz E, Davies M, Jo M, Gates J, Wu J, Zhang X, Lieberman JR,. 2003. Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone. J Orthop Res 21: 62-72. (Pubitemid 36157621)
37. Li ZG, Mathew P, Yang J, Starbuck MW, Zurita AJ, Liu J, Sikes C, Multani AS, Efstathiou E, Lopez A, Wang J, Fanning TV, Prieto VG, Kundra V, Vazquez ES, Troncoso P, Raymond AK, Logothetis CJ, Lin SH, Maity S, Navone NM,. 2008. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. J Clin Invest 118: 2697-2710.
38. Mizuno M, Kuboki Y,. 2001. Osteoblast-related gene expression of bone marrow cells during the osteoblastic differentiation induced by type I collagen. J Biochem 129: 133-138. (Pubitemid 32150490)
39. Moursi AM, Damsky CH, Lull J, Zimmerman D, Doty SB, Aota S, Globus RK,. 1996. Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci 109 (Pt 6): 1369-1380. (Pubitemid 26190487)
40. Moursi AM, Globus RK, Damsky CH,. 1997. Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. J Cell Sci 110 (Pt 18): 2187-2196. (Pubitemid 27448363)
41. Mundy GR,. 2002. Metastasis to bone: Causes, consequences and therapeutic opportunities. Nat Rev Canc 2: 584-593. (Pubitemid 37328925)
42. Noda M, Vogel R,. 1989. Fibroblast growth factor enhances type beta 1 transforming growth factor gene expression in osteoblast-like cells. J Cell Biol 109: 2529-2535. (Pubitemid 19282636)
43. Pistone M, Sanguineti C, Federici A, Sanguineti F, Defilippi P, Santolini F, Querze G, Marchisio PC, Manduca P,. 1996. Integrin synthesis and utilization in cultured human osteoblasts. Cell Biol Int 20: 471-479. (Pubitemid 26379886)
44. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR,. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. (Pubitemid 29282067)
45. Roodman GD,. 2004. Mechanisms of bone metastasis. N Engl J Med 350: 1655-1664.
46. Salasznyk RM, Klees RF, Hughlock MK, Plopper GE,. 2004a. ERK signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells on collagen I and vitronectin. Cell Commun Adhes 11: 137-153. (Pubitemid 41535860)
47. Salasznyk RM, Williams WA, Boskey A, Batorsky A, Plopper GE,. 2004b. Adhesion to Vitronectin and Collagen I Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells. J Biomed Biotechnol 2004: 24-34. (Pubitemid 38856404)
48. Schneider G, Burridge K,. 1994. Formation of focal adhesions by osteoblasts adhering to different substrata. Exp Cell Res 214: 264-269. (Pubitemid 24302401)
49. Schneider GB, Zaharias R, Stanford C,. 2001. Osteoblast integrin adhesion and signaling regulate mineralization. J Dent Res 80: 1540-1544.
50. So A, Gleave M, Hurtado-Col A, Nelson C,. 2005. Mechanisms of the development of androgen independence in prostate cancer. World J Urol 23: 1-9. (Pubitemid 40425164)
51. Stein GS, Lian JB, Owen TA,. 1990. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 4: 3111-3123.
52. Weiss RE, Reddi AH,. 1980. Synthesis and localization of fibronectin during collagenous matrix-mesenchymal cell interaction and differentiation of cartilage and bone in vivo. Proc Natl Acad Sci U S A 77: 2074-2078. (Pubitemid 10089601)
53. Weiss RE, Reddi AH,. 1981. Role of fibronectin in collagenous matrix-induced mesenchymal cell proliferation and differentiation in vivo. Exp Cell Res 133: 247-254. (Pubitemid 11014923)
54. Winnard RG, Gerstenfeld LC, Toma CD, Franceschi RT,. 1995. Fibronectin gene expression, synthesis and accumulation during in vitro differentiation of chicken osteoblasts. J Bone Miner Res 10: 1969-1977.
55. Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, Franceschi RT,. 2000. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem 275: 4453-4459. (Pubitemid 30094689)
56. Yu LY, Pei Y, Xia WB, Xing XP, Meng XW, Zhou XY,. 2007. Effect of fibroblast growth factor 9 on Runx2 gene promoter activity in MC3T3-E1 and C2C12 cells. Chin Med J (Engl) 120: 491-495. (Pubitemid 46510761)
57. Zhang S, Wang J, Bilen MA, Lin SH, Stupp SI, Satcher RL,. 2009. Modulation of prostate cancer cell gene expression by cell-to-cell contact with bone marrow stromal cells or osteoblasts. Clin Exp Metastasis 26: 993-1004.